Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer

Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer

Bibliographic Details
Main Authors: Thomas Kunzke, Fabian T. Hölzl, Verena M. Prade, Achim Buck, Katharina Huber, Annette Feuchtinger, Karolin Ebert, Gwen Zwingenberger, Robert Geffers, Stefanie M. Hauck, Ivonne Haffner, Birgit Luber, Florian Lordick, Axel Walch
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.547
id doaj-a209e45f32244846aabeedb91561d7bf
record_format Article
spelling doaj-a209e45f32244846aabeedb91561d7bf2021-09-29T12:10:39ZengWileyClinical and Translational Medicine2001-13262021-09-01119n/an/a10.1002/ctm2.547Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancerThomas Kunzke0Fabian T. Hölzl1Verena M. Prade2Achim Buck3Katharina Huber4Annette Feuchtinger5Karolin Ebert6Gwen Zwingenberger7Robert Geffers8Stefanie M. Hauck9Ivonne Haffner10Birgit Luber11Florian Lordick12Axel Walch13Research Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyResearch Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyResearch Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyResearch Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyResearch Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyResearch Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar Institut für Allgemeine Pathologie und Pathologische Anatomie München GermanyTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar Institut für Allgemeine Pathologie und Pathologische Anatomie München GermanyGenome Analytics Group Helmholtz Center for Infection Research HZI Braunschweig GermanyResearch Unit Protein Science and Metabolomics and Proteomics Core Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg GermanyUniversity Cancer Center Leipzig (UCCL) Leipzig University Medical Center Leipzig GermanyTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar Institut für Allgemeine Pathologie und Pathologische Anatomie München GermanyUniversity Cancer Center Leipzig (UCCL) Leipzig University Medical Center Leipzig GermanyResearch Unit Analytical Pathology Helmholtz Zentrum München–German Research Center for Environmental Health Neuherberg Germanyhttps://doi.org/10.1002/ctm2.547
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Kunzke
Fabian T. Hölzl
Verena M. Prade
Achim Buck
Katharina Huber
Annette Feuchtinger
Karolin Ebert
Gwen Zwingenberger
Robert Geffers
Stefanie M. Hauck
Ivonne Haffner
Birgit Luber
Florian Lordick
Axel Walch
spellingShingle Thomas Kunzke
Fabian T. Hölzl
Verena M. Prade
Achim Buck
Katharina Huber
Annette Feuchtinger
Karolin Ebert
Gwen Zwingenberger
Robert Geffers
Stefanie M. Hauck
Ivonne Haffner
Birgit Luber
Florian Lordick
Axel Walch
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
Clinical and Translational Medicine
author_facet Thomas Kunzke
Fabian T. Hölzl
Verena M. Prade
Achim Buck
Katharina Huber
Annette Feuchtinger
Karolin Ebert
Gwen Zwingenberger
Robert Geffers
Stefanie M. Hauck
Ivonne Haffner
Birgit Luber
Florian Lordick
Axel Walch
author_sort Thomas Kunzke
title Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
title_short Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
title_full Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
title_fullStr Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
title_full_unstemmed Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
title_sort metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with her2‐positive advanced gastric cancer
publisher Wiley
series Clinical and Translational Medicine
issn 2001-1326
publishDate 2021-09-01
url https://doi.org/10.1002/ctm2.547
work_keys_str_mv AT thomaskunzke metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT fabiantholzl metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT verenamprade metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT achimbuck metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT katharinahuber metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT annettefeuchtinger metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT karolinebert metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT gwenzwingenberger metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT robertgeffers metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT stefaniemhauck metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT ivonnehaffner metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT birgitluber metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT florianlordick metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
AT axelwalch metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer
_version_ 1716864415276466176

Similar Items